Our reports provide evidence that helps to build awareness and support pioneering dementia research in the UK and globally.
Ready for the Cure: A blueprint for UK leadership in dementia research
July 2026
Our Ready for the Cure report lays out three priorities for government: to align the UK’s strengths through national leadership and coordination, build a trial-ready system, and speed up NHS adoption of dementia innovation – so that people affected by dementia can access earlier and more accurate diagnosis, take part in clinical trials, and benefit from new diagnostics and treatments.
Closing the dementia awareness gap: why the UK needs a national dementia risk reduction campaign
April 2026
Alzheimer’s Research UK has called on the government to improve public awareness of the positive steps people can take to protect their brain health, through a national dementia risk reduction campaign.
Dementia treatments: an opportunity to deliver for patients and drive economic growth
December 2025
Our paper lays out crucial steps which the UK government should take to realise the full potential of the rich dementia treatments pipeline.
Seeing the Unseen: Rethinking Dementia Diagnosis
September 2025
A timely, accurate dementia diagnosis can transform lives. Yet too many people still face long waits, uncertainty, or no diagnosis at all. Our new report amplifies the voices of those at the heart of this challenge as they share their experiences and what must change to ensure everyone gets the answers they need.
Delivering Dementia Diagnosis: A blueprint for the future
June 2025
Our Blueprint for Dementia Diagnosis outlines a bold, evidence-based plan to ensure everyone affected by dementia can access a fast, fair, and accurate diagnosis— empowering people to access support, join research, and benefit from new treatments.
Working together to shape and expand brain health clinics across the uk
November 2024
Right now, there isn’t a cure for people with dementia. But hope is on the horizon with lecanemab and donanemab – the first Alzheimer’s treatments licensed in Britain that can slow down the disease, rather than just treating its symptoms.
Improving access to new dementia treatments through data
October 2024
With the first treatments that can tackle the underlying causes of dementia on the horizon, there are many changes that need to be made to ensure the NHS is ready to adopt and deliver them to people who stand to benefit.
Tackling Inequalities in Dementia Risk
October 2023
Health inequalities in the UK are damaging brain health, reducing life expectancy, and incurring significant costs – to individuals and society. These disparities are avoidable, unjust, and on the rise.
Tipping Point: The Future of Dementia
September 2023
Our new report sets out a series of calls for party leaders ahead of the next general election. We believe these recommendations are vital to tackle the increasing pressure that dementia places on society, the NHS, and the economy.
Investing in dementia research boosts UK economy
July 2023
If nothing changes, one in two of us will be directly affected by dementia, either by developing the condition ourselves, caring for someone, or both.
Addressing value and affordability
July 2022
Following a workshop with stakeholders from the NHS, the National Institute for Health and Care Excellence (NICE), industry and academia, we examine the challenges and opportunities in assessing the value and affordability of new Alzheimer’s medicines.
Establishing a Clinical Trials Network
May 2023
The creation of a ‘clinical trials network’ has huge potential to dramatically change the landscape for dementia research in the UK. Here, we set out our recommendations for how such a network could operate and deliver successful outcomes.
A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)
March 2023
Patient charities set out a shared vision for the next VPAS scheme.
Improving dementia diagnosis: what could change in primary care?
November 2022
The search for life-changing dementia treatments is beginning to yield tangible results. Now is the time for primary care to adapt to diagnosing people at the earliest stages of dementia, when treatments are most likely to be effective.
Five steps to delivering life-changing treatments for dementia
August 2022
Alzheimer’s Research UK is calling on the new Prime Minister to follow five key steps to ensure the UK can be a world leader in dementia clinical research and help deliver life-changing treatments.
The Impact of Dementia on Women
May 2022
Dementia devastates the lives of everyone it touches, but our analysis shows that women are bearing a disproportionate weight of the impact.
Dementia Attitudes Monitor: Wave 2 (2021)
September 2021
Wave 2 builds on findings from Wave 1 (2018), shining a light on the UK’s attitudes towards dementia.
Are we ready to deliver disease modifying treatments?
May 2021
Old Age Psychiatrists’ views on diagnosing and treating Alzheimer’s disease before dementia
